Commerzbank shares are riding a wave of bullish momentum, but a hidden regulatory trap in Poland could sink a multi-billion euro takeover attempt. As the German lender’s stock trades near 34.56 EUR, having gained almost ten percent over the past week, a fierce battle over its future is intensifying on two fronts.
The immediate driver for the share price is a decisive technical breakout. The stock has surged past its 200-day moving average at 33.13 EUR, leaving all major trend lines behind and providing shareholders with a solid foundation. This strength will be tested during a critical series of events in May. Management is preparing to underscore its standalone strategy with upgraded financial targets for the year and to reward investors with a significantly higher dividend of 1.10 EUR per share, scheduled for payment on May 25, 2026.
However, the calendar is crowded with potential flashpoints. Commerzbank will release its first-quarter figures on May 8, followed by its annual general meeting on May 20. Preceding these events, UniCredit will hold an extraordinary shareholder meeting on May 4, 2026, to vote on a capital increase intended to fund its pursuit of the Frankfurt-based bank.
That pursuit, led by UniCredit CEO Andrea Orcel, faces mounting complications. The Italian bank’s current share-exchange offer, valued at roughly 35 billion EUR with an implied price of 30.80 EUR per Commerzbank share, has been repeatedly rejected by Commerzbank’s board. Management argues the proposal fails to offer sufficient value compared to its independent plans. Yet, a newly surfaced obstacle from Poland presents an even steeper challenge for UniCredit.
Should investors sell immediately? Or is it worth buying Commerzbank?
Legal documents reveal a clause in Polish capital market law that triggers an automatic mandatory tender offer for Commerzbank’s subsidiary, mBank, if any entity acquires more than 50 percent of the German parent. With nearly 31 percent of mBank in free float, this mandatory offer would carry an estimated price tag of 3.8 billion EUR. Furthermore, Polish regulators firmly oppose a full delisting of the subsidiary, forcing a lasting financial commitment. This “poison pill” scenario dramatically increases the cost and complexity of a hostile majority takeover, a path UniCredit claims it is not currently seeking.
The situation creates a curious paradox. While Commerzbank’s executive board in Frankfurt maintains its defensive posture, its Polish unit is independently negotiating a risk transfer for 1.2 billion EUR in commercial real estate loans with UniCredit. Although these talks are in early stages, this operational cooperation starkly contrasts with the parent company’s official resistance.
Analysts are watching the standoff closely. DZ Bank analyst Philipp Häßler views UniCredit’s expected voluntary takeover bid as a tactical move, primarily designed to pressure Commerzbank into negotiations. It would grant the Italian bank the freedom to increase its stake through market purchases up to the 50 percent threshold. DZ Bank maintains a “Hold” rating on Commerzbank with a fair value estimate of 34 EUR.
The timeline for a resolution is becoming clearer. Germany’s financial regulator, BaFin, is expected to approve UniCredit’s formal offer in May, after which the official acceptance period will begin. A concrete outcome is anticipated by late June or July 2026. Two major barriers remain: the German government, which holds a 12 percent stake and currently blocks a sale, and the newly revealed billion-euro snare waiting in Warsaw. UniCredit itself has acknowledged that the prolonged uncertainty could lead to customer and employee attrition, adding urgency to the complex chess game.
Ad
Commerzbank Stock: Buy or Sell?! New Commerzbank Analysis from April 11 delivers the answer:
The latest Commerzbank figures speak for themselves: Urgent action needed for Commerzbank investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 11.
Commerzbank: Buy or sell? Read more here...
